Revelation Biosciences, Inc.

Revelation Biosciences, Inc.verified

REVB

Price:

$1.68

Market Cap:

$2.74M

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is also involved in developing REVTx-300, a non-clinical stage product that is being developed as a potential therapy for the treatment of chronic organ disease, including chronic kidney disease and non-alcoholic steatohepatitis; and REVDx-501, a rapid t...[Read more]

Industry

Biotechnology

IPO Date

2020-11-17

Stock Exchange

NASDAQ

Ticker

REVB

The PE Ratio as of July 2024 (TTM) for Revelation Biosciences, Inc. (REVB) is -0.03

According to Revelation Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.03. This represents a change of -94.20% compared to the average of -0.52 of the last 4 quarters.

Revelation Biosciences, Inc. (REVB) Historical PE Ratio (quarterly & annually)

How has REVB PE Ratio performed in the past?

The mean historical PE Ratio of Revelation Biosciences, Inc. over the last ten years is -4900.10. The current -0.03 PE Ratio has changed -99.94% with respect to the historical average. Over the past ten years (40 quarters), REVB's PE Ratio was at its highest in in the March 2023 quarter at 0.07. The PE Ratio was at its lowest in in the September 2020 quarter at -7739964.34.

Quarterly (TTM)
Annual

Average

-4900.10

Median

-28.48

Minimum

-24407.21

Maximum

-0.33

Revelation Biosciences, Inc. (REVB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Revelation Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 8.47%

Maximum Annual PE Ratio = -0.33

Minimum Annual Increase = -99.77%

Minimum Annual PE Ratio = -24407.21

Quarterly (TTM)
Annual
YearPE RatioChange
2023-28.488.47%
2022-0.33-96.04%
2021-8.40-85.02%
2020-56.08-99.77%

Revelation Biosciences, Inc. (REVB) Average PE Ratio

How has REVB PE Ratio performed in the past?

The current PE Ratio of Revelation Biosciences, Inc. (REVB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-12.40

5-year avg

-4900.10

10-year avg

-4900.10

Revelation Biosciences, Inc. (REVB) PE Ratio vs. Peers

How is REVB’s PE Ratio compared to its peers?

Revelation Biosciences, Inc.’s PE Ratio is greater than Virax Biolabs Group Limited (-0.30), greater than Blue Water Vaccines, Inc. (-0.17), less than Hillstream BioPharma, Inc. (-0.00), less than Kiora Pharmaceuticals, Inc. (41.57), less than ZyVersa Therapeutics, Inc. (-0.02), greater than Sonnet BioTherapeutics Holdings, Inc. (-0.47), less than Navidea Biopharmaceuticals, Inc. (0.03), greater than Altamira Therapeutics Ltd. (-0.04), greater than Zura Bio Limited (-3.18), greater than Phio Pharmaceuticals Corp. (-2.20), greater than TransCode Therapeutics, Inc. (-0.25), greater than Quoin Pharmaceuticals, Ltd. (-0.15), less than PaxMedica, Inc. Common Stock (-0.01),

Build a custom stock screener for Revelation Biosciences, Inc. (REVB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revelation Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Revelation Biosciences, Inc. (REVB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Revelation Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Revelation Biosciences, Inc.'s PE Ratio?

How is the PE Ratio calculated for Revelation Biosciences, Inc. (REVB)?

What is the highest PE Ratio for Revelation Biosciences, Inc. (REVB)?

What is the 3-year average PE Ratio for Revelation Biosciences, Inc. (REVB)?

What is the 5-year average PE Ratio for Revelation Biosciences, Inc. (REVB)?

How does the current PE Ratio for Revelation Biosciences, Inc. (REVB) compare to its historical average?